In the third quarter, Abacus FCF Advisors LLC boosted its stake in Colgate-Palmolive Company by 11.0%, purchasing an additional 22,105 shares to raise its total holding to 223,175 shares. This investment now represents approximately 2.4% of Abacus FCF’s overall portfolio, making Colgate-Palmolive its 12th largest position. According to the firm’s most recent SEC filing, the value of this holding stood at $17.84 million at quarter end.

Several other institutional investors adjusted their exposures during the same period. Baron Wealth Management LLC added 414 shares for a 7.7% increase, bringing its total to 5,778 shares valued at $462,000. Diversified Trust Co. acquired 10,892 shares (up 12.8%) to reach 96,003 shares worth $7.67 million. Mirova US LLC enlarged its position by 50.9%, purchasing 9,614 shares for a total of 28,494 shares valued at $2.28 million. Chemung Canal Trust Co. added 200 shares (1.1% increase) to reach 18,886 shares, and Annex Advisory Services LLC grew its stake by 2.4% with 2,437 additional shares, totaling 106,068 shares valued at $8.48 million. Hedge funds and other institutions now control over 80% of the company’s outstanding stock.

In recent weeks, research firms have adjusted their views on Colgate-Palmolive. Deutsche Bank set an $86 target, Morgan Stanley cut its target to $87 while maintaining an overweight rating, Barclays lowered its target to $80 with an equal-weight rating, and JPMorgan increased its target to $88 and retained an overweight stance. Bank of America adjusted its objective to $88 and kept a buy rating. Among 16 analysts covering the stock, ten carry Buy ratings, five are Hold, and one is Sell, resulting in an average consensus of Moderate Buy and an average target of $88.81.

For the quarter ended October 31, Colgate-Palmolive reported earnings of $0.91 per share, beating consensus estimates by $0.02, on revenue of $5.13 billion—down slightly from analyst expectations. Year-over-year revenue grew 1.9%, and the company delivered a net margin of 14.5% and return on equity exceeding 330%. The board declared a quarterly dividend of $0.52 per share, payable on February 13 to shareholders of record as of January 21, representing an annualized payout of $2.08 and a yield of 2.6%.